MDACC

Houston, Texas 77030

5 studies enrolling now · 10 studies all time

What they study most

ALL, AML, AML, Adult, Advanced Hematologic Tumors, Advanced Solid Tumor, Advanced Solid Tumors, Advanced Urothelial Cancer, Blast Crisis, Chronic Lymphocytic Leukemia, Hematologic Malignancies, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute

Studies at this site

• Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer — Recruiting now
• A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors — Recruiting now
• A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) — Recruiting now
• Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion — Recruiting now
• APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies — Recruiting now
• A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors — Stopped early
• A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer — Running, not enrolling
• A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML) — Status unconfirmed
• Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma — Completed
• Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies — Completed